PrimeVigilance Enhances Efficiency and Patient Safety with Oracle Argus Platform

Contract Research Organization aims to improve data management, accuracy, and safety with Oracle's AI-powered pharmacovigilance platform

AUSTIN, Texas, July 8, 2025 /PRNewswire/ -- Contract Research Organization (CRO), PrimeVigilance, is significantly enhancing its service offerings with Oracle Argus. Delivering the full lifecycle of pharmacovigilance services, the CRO is leveraging Argus to provide its clients with a powerful, AI-driven solution to help optimize their drug development programs and support patient safety and regulatory compliance. PrimeVigilance is part of the Ergomed Group whose mission is to deliver leading solutions that support its customers' clinical projects to speed the development of new drugs.

"Changing regulations and the rapid increase of data from new sources demand improved safety strategies," said Sally Amanuel, president, PrimeVigilance. "Using the AI-powered Oracle Argus platform, we can enhance safety monitoring, drive efficiency, and empower our teams to focus on value-added activities that can help to improve patient outcomes for our clients."

Oracle Argus is a leading pharmacovigilance safety platform that handles 10 million adverse event cases each year, providing the benchmark platform for processing, analyzing, and reporting safety data at scale for clinical trials.

Accelerating safety
PrimeVigilance also recently became an Oracle Lighthouse development program collaborator for Argus. PrimeVigilance will bring its CRO perspective to this innovation program with goals of further accelerating pharmacovigilance excellence across the life sciences industry to increase operational efficiency, optimize data management and regulatory compliance, and enhance patient safety insights.

"Oracle Argus has been the gold standard in pharmacovigilance for decades," said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. "Working with organizations like PrimeVigilance we are building on that excellence to deliver cloud-based, AI-enabled solutions that improve safety monitoring for the benefit of the industry and the patients waiting for potentially lifesaving solutions."

About PrimeVigilance
PrimeVigilance, an Ergomed Group Limited company, is the leading pharmacovigilance specialist provider delivering global solutions for clinical safety and post-marketing pharmacovigilance and medical information from operational hubs based in Europe, the U.S., India, and Japan. Our extensive experience allows us to provide comprehensive, high-quality, cost-effective, and innovative safety solutions.

Our flexible, customized approach allows us to deliver services that align with client clinical and post-marketing needs. We provide pharmacovigilance solutions to 200+ clients who distribute their products worldwide and manage a comprehensive global pharmacovigilance system. For more information, visit www.primevigilance.com or contact [email protected].

About Oracle Life Sciences
Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance, throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years of experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements—empowering the Life Sciences industry to improve patient outcomes. Learn more at www.oracle.com/lifesciences.

About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at oracle.com.

Trademarks
Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

SOURCE Oracle